Abstract
A new strain of the old pandemic, Monkeypox (MPX), has emerged with a more complicated clinical appearance. It is a source of relief that the fatality rate in the new monkeypox is lower, but communicability is higher. This infection’s diagnosis and therapy are still challenging and unknown. Researchers are reporting increased human-to-human transmission in the modified version of MPX. There have been several reports of the updated version of monkeypox in the European and American areas. Brazil, Colombia, France, Spain, Germany, Peru, the United Kingdom, and the United States of America have recorded over three thousand new cases of monkeypox through October 2022. Few antiviral medicines and vaccines are available on the market, making treatment of this condition difficult. MPX was previously declared an epidemic disease, but ignorance about it can bring devastation in the shape of the next pandemic-like COVID-19. This review aims to assess the virology, transmission, diagnosis, and therapy of MPX.
Publisher
Journal of Pure and Applied Microbiology
Subject
Applied Microbiology and Biotechnology,Microbiology,Biotechnology
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献